We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Boosting the Efficacy of A Key Cancer Treatment

News   Feb 21, 2017 | Original story from Sbarro Health Research Organization

 
Boosting the Efficacy of A Key Cancer Treatment

MicroRNA-125a-5p is a downstream effector of sorafenib in its antiproliferative activity toward human hepatocellular carcinoma cells. Credit: Sbarro Health Research Organization

 
 
 

RELATED ARTICLES

Multiple Malware Threats for Visitors to Pirate Websites

News

Over 4 000 files containing malware or potentially unwanted programmes were retrieved from more than 1 000 websites suspected of sharing illegally protected content in an EU-wide research project carried out by the European Union Intellectual Property Office (EUIPO).

READ MORE

Genetic Similarities Found Across Multiple Cancer Types

News

Study could lead to new treatments for advanced epithelial cancers such as lung and prostate cancers.

READ MORE

DNA Traces Illegal Ivory Shipments Back to Major Cartels

News

The international trade in elephant ivory has been illegal since 1989, yet African elephant numbers continue to decline. A study reports that DNA test results of ivory seizures made by law enforcement have linked multiple ivory shipments to the same network of dealers operating out of a handful of African ports.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE